Does treat to target or achieving remission improve radiographic outcome in psa?

Documents similaires

• What should be the primary target of ‘treat to target’ in PsA?
  par: Coates, L, et autres
  Publié: (2018)
• What should be the primary target of "treat to target" in psoriatic arthritis?
  par: Coates, LC, et autres
  Publié: (2018)
• Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment
  par: Coates, LC, et autres
  Publié: (2021)
• Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
  par: Coates, L, et autres
  Publié: (2022)
• Treat-to-target in PsA: methods and necessity
  par: Dures, E, et autres
  Publié: (2020)